1. Home
  2. CTMX vs ICLK Comparison

CTMX vs ICLK Comparison

Compare CTMX & ICLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • ICLK
  • Stock Information
  • Founded
  • CTMX 2008
  • ICLK 2009
  • Country
  • CTMX United States
  • ICLK Hong Kong
  • Employees
  • CTMX N/A
  • ICLK N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • ICLK Computer Software: Prepackaged Software
  • Sector
  • CTMX Health Care
  • ICLK Technology
  • Exchange
  • CTMX Nasdaq
  • ICLK Nasdaq
  • Market Cap
  • CTMX 85.3M
  • ICLK 73.0M
  • IPO Year
  • CTMX 2015
  • ICLK 2017
  • Fundamental
  • Price
  • CTMX $0.84
  • ICLK $8.99
  • Analyst Decision
  • CTMX Buy
  • ICLK
  • Analyst Count
  • CTMX 6
  • ICLK 0
  • Target Price
  • CTMX $5.77
  • ICLK N/A
  • AVG Volume (30 Days)
  • CTMX 1.2M
  • ICLK 93.8K
  • Earning Date
  • CTMX 03-10-2025
  • ICLK 11-27-2024
  • Dividend Yield
  • CTMX N/A
  • ICLK N/A
  • EPS Growth
  • CTMX N/A
  • ICLK N/A
  • EPS
  • CTMX 0.16
  • ICLK N/A
  • Revenue
  • CTMX $126,617,000.00
  • ICLK $130,443,999.00
  • Revenue This Year
  • CTMX $22.55
  • ICLK $26.49
  • Revenue Next Year
  • CTMX N/A
  • ICLK $12.11
  • P/E Ratio
  • CTMX $5.20
  • ICLK N/A
  • Revenue Growth
  • CTMX 33.66
  • ICLK N/A
  • 52 Week Low
  • CTMX $0.79
  • ICLK $1.03
  • 52 Week High
  • CTMX $5.85
  • ICLK $11.38
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 33.95
  • ICLK 56.06
  • Support Level
  • CTMX $0.79
  • ICLK $8.01
  • Resistance Level
  • CTMX $1.17
  • ICLK $9.32
  • Average True Range (ATR)
  • CTMX 0.08
  • ICLK 0.99
  • MACD
  • CTMX -0.03
  • ICLK -0.23
  • Stochastic Oscillator
  • CTMX 13.16
  • ICLK 41.56

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About ICLK iClick Interactive Asia Group Limited

iClick Interactive Asia Group Ltd is an enterprise and marketing cloud Platform in China. It offers a consumer full lifecycle solution that addresses client's needs from traffic acquisition, customer relations management, and business decision optimization driven by data analytics in the retail era. It has two operating segments: Marketing Solutions, and Enterprise Solutions. Geographically, it derives the majority revenue from Mainland China and also has a presence in Hong Kong and other countries.

Share on Social Networks: